Navigation Links
VITAS Innovative Hospice Care(R) Names Christopher Rieder Senior Vice President and Chief Information Officer
Date:2/24/2009

MIAMI, Feb. 24 /PRNewswire/ -- VITAS Innovative Hospice Care(R) announced today that Christopher Rieder has been named senior vice president and chief information officer. In his new position, Rieder will oversee planning and implementation of IT operations throughout VITAS to support the company's strategic direction.

Rieder has more than 20 years of IT experience with global organizations translating business objectives into technology solutions. He has worked extensively with pharmaceutical and biotechnology companies.

Rieder most recently was chief information officer and vice president at Parexel, Inc., a leading bio-pharmaceutical services organization. At Parexel, Rieder led the company's worldwide technology initiatives, including integration of technology solutions, information management and business processes. Prior to that position, Rieder served as vice president of information technology for Kos Pharmaceuticals, where he built a customer- centric IT division to improve the company's customer service operations.

"Chris's experience at the senior management level will make him a superb asset to our organization," said David Wester, VITAS president and chief financial officer. "His ability to bring a working knowledge of technology to corporate initiatives will help us continue to offer innovative solutions for providing exceptional end-of-life care to our patients and their families."

Rieder holds an MBA in information technology from American University in Washington, D.C., and a BSBA in business economics and pre-medicine from the University of Arizona. A member of the Society for Information Management, Rieder was a contributing author of the book, "Improving Technology ROI: Leading CTOs and CIOs on Making Successful Technology Investments, Maximizing Return on Investments, & Gaining a Competitive Edge (Inside the Minds)."


'/>"/>

SOURCE VITAS Innovative Hospice Care(R)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Navitas Names Dr. Dean Gesme as Medical Director
2. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
3. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System
4. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
7. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
8. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug
9. Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis
10. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
11. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... US-Australian drug discovery company, Novogen Limited (ASX: NRT; NASDAQ: ... progressing its ground-breaking technology platforms to Phase 1 clinical ... Company delivers the best value for shareholders. ... the Company currently had an extensive program of activities ... academic partnerships and initiatives, and he was working with ...
(Date:7/29/2015)... July 29, 2015  HealthSouth Corporation (NYSE: ... providers of post-acute healthcare services, offering both facility-based ... of operations for the second quarter ended June 30, ... characterized by strong volume growth in both segments ... said Jay Grinney, President and Chief Executive Officer ...
(Date:7/29/2015)... , July 29, 2015 ... has announced the addition of the "Global ... their offering. The Global Biosimilars Market, ... of the rapidly growing biosimilars market. With the ... striving to minimize costs, biosimilars are being viewed ...
(Date:7/29/2015)... YORK , July 29, 2015  Therapath ... testing, announces increased partnerships with VA and Military ... Epidermal Nerve Fiber Density (ENFD) and Sweat Gland ... small fiber neuropathy ( https://therapath.com/skin ). ... Nerve Fiber Density (ENFD) on punch skin biopsy ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17HealthSouth Reports Results for Second Quarter 2015 18HealthSouth Reports Results for Second Quarter 2015 19HealthSouth Reports Results for Second Quarter 2015 20HealthSouth Reports Results for Second Quarter 2015 21HealthSouth Reports Results for Second Quarter 2015 22HealthSouth Reports Results for Second Quarter 2015 23HealthSouth Reports Results for Second Quarter 2015 24HealthSouth Reports Results for Second Quarter 2015 25HealthSouth Reports Results for Second Quarter 2015 26HealthSouth Reports Results for Second Quarter 2015 27
... 4 Human Genome,Sciences, Inc. (Nasdaq: HGSI ... - Thomson Financial 14th Anniversary NewsMakers in the ... accessed at, http://www.hgsi.com . (Logo: ... Genome Sciences, senior management team will present,an overview ...
... Colo., Sept. 4 Allos,Therapeutics, Inc. (Nasdaq: ... and commercialization of small molecule therapeutics for,the treatment ... President and,CEO, will present a corporate overview at ... York. The Company,s presentation will take place ...
... Model, Selection and Bias; Dr. Klaas Prins to Present on ... ... Using Metadata, MOUNTAIN VIEW, Calif., Sept. 4 ... and,strategic services for optimizing clinical drug development, today,announced that Pharsight ...
Cached Biology Technology:Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference 2Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007 2Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007 3
(Date:7/31/2015)... , Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market and ... has filed provisional patent 62/198989 for ELECTRONIC ... highlights a method to advance crypto-currencies such as Bitcoin ... a common, uniform way to manage all payments.  ...
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier of ... second quarter ended June 30, 2015.  Revenue ... decrease of 33% compared to $6.8 million in the same ... 2015 was $0.3 million, or $0.01 per diluted share, which ... the same period a year ago.  Lower ...
(Date:7/20/2015)... July 20, 2015  Acuity Market Intelligence,s latest ... Convergence of Commerce and Privacy" forecasts that between ... apps will be downloaded to smart mobile devices ... biometrics market is projected to generate more than ... the seven-year forecast period.    "Biometrics ...
Breaking Biology News(10 mins):NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... most severe form of that group of diseases, affects 500 ... by a protozoan, Leishmania infantum, transmitted by sand fly bites. ... lead to death if no treatment is given. In the ... by infection. It acts as parasite reservoir for humans. Development ...
... that it has discovered a new class of ... infection. Biota has filed worldwide patents and selected ... for further preclinical development prior to human clinical ... need and already a billion-dollar market, with growing ...
... a medically important fungus, causing potentially life-threatening infections in ... major cause of respiratory allergy, and it is implicated ... thought to lack the ability to reproduce sexually, but ... that the fungus has a number of characteristics of ...
Cached Biology News:Visceral Leishmaniasis: Successful Vaccine Trial In Dogs 2Visceral Leishmaniasis: Successful Vaccine Trial In Dogs 3Visceral Leishmaniasis: Successful Vaccine Trial In Dogs 4Biota makes major antiviral discovery 2Secret sex life of killer fungus? 2
... traps a wide variety of solvent vapors that ... glass condensation flask (GCF400) allows for the collection ... easy draining. Rapid cooling time minimizes waiting period., ... quick solvent changes , -50?C ...
... Protein Phosphatase-2A (PPase-2A) is a serine/threonine phosphatase ... is isolated as the heterodimer of 60kDa ... the ability to dephosphorylate the a-subunit of ... PPase-2A has broad substrate specificity and may ...
... high performance spectral scanning multimode reader ... the advanced SkanIt Software it offers ... discovery assay development. Varioskan provides unlimited ... fluorescence and photometric assays and a ...
... of solvent vapors that can contaminate and degrade vacuum ... the collection of liquid into a self contained jar ... Ultra low -104 o C temperature ... Digital Display of temperature ...
Biology Products: